Lrp4 is a receptor for Agrin and forms a complex with MuSK.

Lrp4 is a receptor for Agrin and forms a complex with MuSK.

Neuromuscular synapse formation requires a complex exchange of signals between motor neurons and skeletal muscle fibers, leading to the accumulation of postsynaptic proteins, including acetylcholine receptors in the muscle membrane and specialized release sites, or active zones in the presynaptic ne...

書誌詳細
主要な著者:	Kim, N, Stiegler, A, Cameron, T, Hallock, P, Gomez, A, Huang, J, Hubbard, SR, Dustin, M, Burden, S
フォーマット:	Journal article
言語:	English
出版事項:	2008

類似資料

A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.
著者:: Asma Ben Ammar, 等
出版事項: (2013-01-01)

Correction: A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia
出版事項: (2013-01-01)

Correction: A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia.
著者:: Asma Ben Ammar, 等
出版事項: (2013-01-01)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters
著者:: Koneczny, I, 等
出版事項: (2013)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
著者:: Koneczny, I, 等
出版事項: (2013)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
著者:: Inga Koneczny, 等
出版事項: (2013-01-01)

Agrin Influences Botulinum Neurotoxin A-Induced Nerve Sprouting via miR-144-agrin-MuSK Signaling
著者:: Lin Ma, 等
出版事項: (2020-01-01)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
著者:: Koneczny, I, 等
出版事項: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
著者:: Koneczny, I, 等
出版事項: (2014)

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
著者:: Leite, M, 等
出版事項: (2005)

Myasthenia gravis with MuSK antibodies
著者:: Farrugia, M, 等
出版事項: (2005)

Potential mechanisms in MuSK-myasthenia gravis
著者:: Koneczny, I
出版事項: (2014)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
著者:: Shalini Bhaskar, 等
出版事項: (2022-01-01)

Synapse-specific Lrp4 mRNA enrichment requires Lrp4/MuSK signaling, muscle activity and Wnt non-canonical pathway
著者:: Hongyang Jing, 等
出版事項: (2021-06-01)

Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
著者:: Jamie L. Lim, 等
出版事項: (2025-02-01)

Increasing MuSK Activity Delays Denervation and Improves Motor Function in ALS Mice
著者:: María J. Pérez-García, 等
出版事項: (2012-09-01)

Infantile Onset Myasthenia Gravis with MuSK Antibodies
著者:: J Gordon Millichap
出版事項: (2006-08-01)

Studies of the MuSK system using molecular dynamics simulations
著者:: Buyan, A
出版事項: (2015)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
著者:: Vincent, A, 等
出版事項: (2006)

Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody
著者:: Sarah Cantor, 等
出版事項: (2018-02-01)

Clinical aspects of MuSK antibody positive seronegative MG.
著者:: Sanders, D, 等
出版事項: (2003)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
著者:: McConville, J, 等
出版事項: (2004)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
著者:: Lee, J, 等
出版事項: (2006)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
著者:: Shiraishi, H, 等
出版事項: (2005)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
著者:: Nilesh Wagh, 等
出版事項: (2024-09-01)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
著者:: Carmelo Rodolico, 等
出版事項: (2020-07-01)

Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
著者:: Farrugia, M, 等
出版事項: (2007)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
著者:: Yamanashi, Y, 等
出版事項: (2008)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
著者:: Bennett, D, 等
出版事項: (2006)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
著者:: Diana Epure, 等
出版事項: (2016-06-01)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
著者:: Ting LI, 等
出版事項: (2020-01-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
著者:: Yung-Chuan Huang, 等
出版事項: (2008-07-01)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
著者:: Hoch, W, 等
出版事項: (2001)

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
著者:: Phillips, W, 等
出版事項: (2015)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
著者:: Chang, T, 等
出版事項: (2009)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
著者:: Newsom-Davis, J, 等
出版事項: (2001)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
著者:: Cao, M
出版事項: (2021)

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
著者:: Fangyi Shi, 等
出版事項: (2024-11-01)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
著者:: Amber Eker, 等
出版事項: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
著者:: Zunwei Zhang, 等
出版事項: (2020-10-01)